S.Korea's Celltrion to merge with affiliates to set up holding company structure

Celltrion Pharm

25/09/2020 08:20

SEOUL, Sept 25 (Reuters) - South Korean pharmaceutical
company Celltrion  068270.KS  said in a regulatory filing on
Friday that it plans to merge with affiliates Celltrion
HealthCare  091990.KQ , Celltrion Pharm  068760.KQ  to establish
a holding company structure by end-2021. 
    Celltrion, whose experimental COVID-19 treatment has been
approved by South Korea for Phase 2/3 clinical trials, said the
merger will take place when requirements for South Korean fair
trade rules are met.  urn:newsml:reuters.com:*:nL4N2GE2SN

 (Reporting by Joyce Lee. Editing by Jane Merriman)
 ((jungyoon.lee@tr.com; +82 2 6936 1467;))